Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03633188Terminated
Open-label, single-arm trial, sponsored by Hospices Civils de Lyon. Primary endpoint: Change in the gut microbiota after treatment at week 26. Started Jul 2018; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03633188.